Intended for healthcare professionals

  1. News & Views
  2. Response to the...
  3. Response to the emerging novel coronavirus outbreak
Editorials

Response to the emerging novel coronavirus outbreak

BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m406 (Published 31 January 2020) Cite this as: BMJ 2020;368:m406

Read our latest coverage of the Coronavirus outbreak

Related articles

  • No related articles found.

See more

Cited by...

  • COVID-19 in patients with hepatobiliary and pancreatic diseases: a single-centre cross-sectional study in East London
  • Association of outpatient ACE inhibitors and angiotensin receptor blockers and outcomes of acute respiratory illness: a retrospective cohort study
  • COVID-19 in patients with hepatobiliary and pancreatic diseases: A single-centre cross-sectional study in East London
  • Role of Drugs used for chronic disease management on Susceptibility and Severity of COVID-19: A Large Case-Control Study
  • Association between angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers use and the risk of infection and clinical outcome of COVID-19: a comprehensive systematic review and meta-analysis
  • Losartan promotes cell survival following SARS-CoV-2 infection in vitro
  • Dangers of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence
  • Potential roles of social distancing in mitigating the spread of coronavirus disease 2019 (COVID-19) in South Korea
  • Can Chinas 'standard of care for COVID-19 be replicated in Europe?
  • COVID-19 as an Acute Inflammatory Disease
  • Coronavirus Disease 2019-COVID-19
  • Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review
  • Regulation of angiotensin converting enzyme 2 (ACE2) in obesity: implications for COVID-19
Back to top